text:
Change in the shareholding of Ahlstrom Corporation
Munksjö invests in a new storage centre at its specialty paper mill in Rottersac, France, to further improve customer service
Helsinki, Finland, 2015-07-02 10:00 CEST (GLOBE NEWSWIRE) --
MUNKSJÖ OYJ, PRESS RELEASE, 2 July 2015 10.00 a.m. CEST
Munksjö invests in a new storage centre at its specialty paper mill in
Rottersac, France, to further improve customer service
Munksjö, a world-leading manufacturer of advanced paper products, steps up
initiatives to support activities of its Rottersac Mill, France: investment in
a totally new storage centre, improvement of production equipment and
implementation of a customer service centre for Europe.
The company has announced an investment project in the building of a totally
new 9,100 m² storage centre. Almost all output is to be stored on-site. This
investment will ease logistic flows, reduce carbon foot print and enable a
better quality control of packaging, leading to a better service to our
customers. The new facility will be ready in 2016.
The Group also invested in 2014 in the mill production assets through new
equipment combining two coating surface devices (size press and film press).
This state-of-the art technology enables a specific coating on the two sides of
the paper, opening new possibilities for new product development. For instance,
it allows for a better paper quality or specific functionalities to meet the
increasingly demanding market expectations.
The new European customer service centre will strengthen Munksjö's
competitiveness by grouping sales support to one hub per Business Area, and for
Graphics and Packaging it will be located at the Rottersac Mill close to the
production. This new organisation will enable flexibility in resources and
teams enabling even better customer service.
"These initiatives and investments translate the willingness of the Group to
support activities and dynamism of the Rottersac Mill. Developing new products,
improving quality and customer service are vital to maintain a leading market
position in a very competitive environment." comments Thierry Chassagne,
Rottersac Mill Manager.
The Rottersac Mill employs approximately 200 employees and is part of the
Business Area Graphics and Packaging. This production site is specialized in
the manufacturing of specialty papers for food and non-food flexible packaging,
repositionable notes, envelop windows and other industrial applications. In
everyday life, these papers are for instance used for baking, packaging of
sweets or cheese, to name a few. The site is certified according to ISO
9001:2008, ISO 14001:2004, OHSAS 18001:2007, FSC® and PEFC Chain-of-Custody.
Munksjö Oyj
Thierry Chassagne, Rottersac Mill Manager, tel. +33 (0)5 5361 5401,
thierrry.chassagne@munksjo.com
Munksjö - Intelligent paper technology
Munksjö is a world-leading manufacturer of advanced paper products developed
with intelligent paper technology. Munksjö offers customer-specific innovative
design and functionality in areas ranging from flooring, kitchens and
furnishings to release papers, consumer-friendly packaging and energy
transmission. The transition to a sustainable society is a natural driving
force for Munksjö's growth as the products can replace non-renewable materials.
This is what "Made by Munksjö" stands for. Given Munksjö's global presence and
way of integrating with the customers, the company forms a worldwide service
organisation with approximately 2,900 employees and 15 facilities located in
France, Sweden, Germany, Italy, Spain, Brazil and China. Munksjö's share is
listed on Nasdaq in Helsinki and Stockholm. Read more at www.munksjo.com.


text:
Hiromi oshima. オオシマ・ヒロミ 2019-07-26
Hiromi oshima Rating: 4,9/10 744 reviews
オオシマ・ヒロミ
She appeared in the 2005 Playmates at Play at the Playboy Mansion swimsuit calendar as the January calendar girl. Oshima currently is one of the members of The Playmate Dancers dance troupe, which is composed entirely of former Playmates. . Hiromi Oshima — Stunning Japanese Model Birth name: Hiromi Oshima Date of Birth: 6 January 1980 Place of Birth: Tokyo, Japan Nationality: Japanese Occupation: Model Height: 5 ft 4 in; 1. Behind the scene photo shoot with model Hiromi Oshima shooting for rukusmag. She has been listed as a Photo Production Coordinator in various issues of Playboy Special Editions.
Top 10 Playboy Japan centerfolds
She appeared in a number of music videos, commercials and in few movies. Her sizzling pictorials have since appeared in 12 additional Playboy Special Editions and she has shown off her fabulous physique in eight steamy Playboy videos. Prior to her 2004 centerfold, Oshima was the covergirl of the 2003 Playboy Special Editions Exotic Beauties, and she appeared in a pictorial of models auditioning for The 50th Anniversary Playmate Hunt in the December 2003 Playboy. Angela Melini continues to work for the Bunny brand as a popular feature reporter for the Playboy Channel. Her turn-ons include long walks along the beach, sunsets, love songs, and soft kisses, and her turnoffs include male bikini briefs.
Hiromi Oshima lives in Miami where she enjoys shopping, dancing and spending quality time with her friends. It was Playboy's first attempt at creating a non-nude swimsuit calendar featuring Playmates similar in style with those from the Sports Illustrated swimsuit issue. Interesting Facts: Hiromi is fluent in Japanese, Spanish and English. Go to or to Always remember that true beauty comes from within. Quotes: I love my body.
The first Japanese-born Playmate was Lieko English who appeared in the June 1971 issue of Playboy. She has since starred in a number of highly touted Playboy videos, as well as in numerous Playboy Special Edition issues. Number 2 Angela MeliniA native of Saigon, South Vietnam, Angela Melini set her career in motion in June 1992 when she made her first of many appearances as a Playboy Japan centerfold. The calendar was the inaugural Playmates at Play calendar, and it was shot on the grounds of the Playboy Mansion in 2004. Page 3 of 3 Number 3 Francine DeeA native of , began her career as an exotic dancer in Las Vegas before a savvy Playboy talent scout snatched her up in 1999 for her first of many Special Edition issues of the magazine. In addition to appearing in the June 2004 Playboy centerfold, she has also starred in a number of Playboy videos as well as Playboy Special Editions. Hiromi has appeared in several episodes of The Girls Next Door reality show on the E! While all Playmates appeared in bikinis in the calendar, only Oshima and Karen McDougal were sporting painted-on bikinis.
Hiromi Oshima was shot by Chris Fortuna for Playboy
Who is Hiromi Oshima dating? Hiromi Oshima boyfriend, husband

redpajama_set_name: RedPajamaCommonCrawl


Did Paleo improve your Ankylosing Spondylitis?
I don't have ankylosing spondylitis myself, but I know someone who does. I'd like her to try going paleo for a little while.
Does anyone out there with AS have a paleo story to share? How long did it take you to notice changes? What got better? What got worse? What didn't change?
My O3/6 ratio definitely improved when I became VERY carefull about the vegetable oils. I think I get 700mg EPA / 500mg DHA in my Omega pills and I now take krill oil (from GNC) too. I don't take any magnesium supplement by itself but there is 100mg of magnesium in my multi. (I introduced tomatoes back in my diet with no change BTW).
I am interested what will happen if you combine gluten removal + omega3 and serious magnesium supplementation (magnesium suppletion is problematic in the sense that it is difficult to get enough!).
How was your omega 3/6 ratio? And did you supplement magnesium?
Namby, I am curious. Do you supplement magnesium? Have you ever had an intracellular RBC Mag test which assesses mag stores?
Personally I believe in the value of leaves, sprouts and shoots and a some heirloom (non gmo) fruit. Im not certain how much the optimal diet embraced either vegetables or nitrate preserved meatd, and perhaps there is a number of factors that affect stomach cancer. Id like to see studies on'glucose' deficiency and effects on mucosal linings. Are there any??? Mucous linings are affected by many things... omega 3, hydration, gut flora, magnesium, potassoim, etc. There is a risk benefit to all approaches and we are all unique in our ancestral background and extent of SAD damage.
Didn't Peter observe that those who followed Dr. K's optimal diet succumbed to stomach / GI cancer in large numbers? Caused in part by glucose deficiency which induced mucosal dryness? Peter did say this could also be due to the consumption of cured meats in Poland, but the number of those who died from cancer was rather alarming.
Meng, AS is connective-tissue related. Do you think an IBS-tailored diet will nonetheless be helpful?
That's why I like paleo -- it is the best protection against nasty pharmaceuticals.
Often paleo is insufficent to reverse neoLETHAL damage -- the immune system needs help. And I'd agree -- no food/supplement will help substancially while the allergen or instigator/trigger is still around (e.g. gluten, dairy, phytic acid, egg whites, nightshade, whatever). My sister (who had autoimmune Grave's -- probably some HLA or vitamin D related variant) always says that we are ALL loaded guns (*haa* or big CANONS) with different susceptibilities... just takes one trigger finger.
Good question! I guess it would very much depend on the stage of the AS. Once you have the typical 'bamboo-spine', that would (probably) be impossible to reverse.
I do have AS, dx 5 yrs, symptomatic for 25 yrs. Started down Paleo road 1/1/10, with IF, and I do eat some dairy. So far, down 45 lbs, have reached goal weight. Quit taking statins. Bloodwork in early July is best in my adult life: TC 181, TG 66, HDL 64, RATIO = 2.8.
I have noticed moderate changes in pain, for the better, and also increased energy. I still need meds to control pain, but feel they are more effective when I eat "on plan."
Ebringer (guy whose team developed the London AS Diet) also showed that Crohn's Disease (which I have) is probably a klebsiella related disease. For the past year I've been eating very low carb, zero starch, zero fiber in an attempt to keep Crohn's in remission. So far, it looks like I've been successful.
I spent a few months in the beginning with flare-up type symptoms, lost about ten pounds. Then in the next few months things stabilized. By month six my weight was back above pre-diet levels. Now, on day 364, I feel fine and have no Crohn's symptoms.
I don't know how applicable to AS this will be, but maybe the fact that I'm going off the same diet for the same reason to attack an auto-immune disorder is a stroke in favor of the diet.
Hey, all of you guys should check out this study a French doctor performed on the effects of wheat-free, dairy free(pretty much paleo) diet. It showed a 96% success rate in the treatment of Ankylosing Spondylitis. Out of 100 cases, 63 had total remissions, 33 had at least a 90% improvement in symptoms, with only 4 failures to improve symptoms at least 50%.
I've suffered from Non-Ankylosing Spondylitis for eight years. 6 months ago I started a strict Paleo diet to see if it would help and I'm pleased to say that it was immensely successful! I used to take diclofenac on a regular basis for near-constant back pain but no longer need it. My back feels better than ever.
I decided to give the Paleo/primal lifestyle a try a little more than 6 months ago, and although it really helped with my digestive issues (suspected crohn's disease) I have to admit that it didn't help with the pain in my joints... I still need the pain meds, and still can't run or perform some movements - even when taking them.
I'm definitely not going back to a SAD (or SFD for me.. I'm french!) since my health has substantially improved during the last 6 months, but I'm not sure if a paleo diet can cure AS. It guess it could, if tried early in the disease progression (i.e. before nerve damage occurs)?
Edit: I need to update this info in case someone would come across this post: my joint pain is now almost entirely gone. What's the Big change? I became more stringent about my diet: I got rid of most nightshades. I don't eat a single mg of gluten (eggs and dairy seem to be OK for me though).
Peter at blog hyperlipid was once a suffered of AS. Couldn't even move at the worse point.
He's completely fine now -- on the Optimal Diet by polish physician DR. Jan Kwasniewski MD, which is essentially evo/primal/paleo. Dr. Kurt Harris follows nearly the same (no potatoes i believe).
For AS -- omega-3, magnesium, trace minerals, vitamin D, thyroid, pancreatic/gut dysbiosis correction -- like all autoimmune diseases are very important to address and replenish for full recovery. Removing neolithic grains, legumes, and eating whole real food (organic, pesticide residue free, blah blah blah) is key of course too.
I don't have AS, but I am HLA-B27 positive and have found that the diet has pretty much reduced my symptoms to nil. My father has Reiter's syndrome and has to inject himself with Humira...I don't want that to be me, ever.
You may be interested, in Robb Wolf's latest podcast he actually talks about this.
At the Robb Wolf seminar I met someone who said they had AS and after about 6 weeks of paleo, combined with both MD and ND care they have it completely manageable.
It seems the diet on its own may not be enough, but having that source of inflammation completely cut off makes the other components more effective.


text:
Robert Chase
Haven't Heard That One in a While…
Missoulaevents.net
The New Show
EEO&Public File
Vinally Friday – 10/26
10/25/2018 by Trail Guide
As much as we love it, nothing triggers the feeling of the endless time warp like the holiday season.
Most of this has to do with family roles: No matter how much we age, when we meet our family around the dining table it's nearly impossible to avoid slipping into old patters and behaviors. The "family system," they call it.
Then there's the obvious seasonal repeats: The songs, the decorations, the sales. Oh my.
When school goes back into session, we realize it's coming. When the leaves start to fall, we recognize there's no going back. But we're absolutely sure the rituals of another holiday season has arrived when Rocky Horror Show Live begins its annual production at the end of each October.
In what has become almost a rite of passage in Missoula, the audience-interactive stage show that blends orgiastic sex, bondage and aliens into a musical song and dance will return to the Wilma for its seventh year this Friday and Saturday.
Presented by Montana Actors' Theatre, the show provides both reserved and tabled seating for 7 pm and 11 pm shows, with a pre-show hosted by the Cigarette Girls Burlesque.
Tomorrow, for this week's edition of Vinally Friday, Alanya will preview the show with a few of her favorite cuts from RHPS's original movie soundtrack.
Also on the turntable:
• Last week Robert introduced us to Willpower, the 1989 greatest hits collection for Scottish singer/songwriter and bassist Jack Bruce. This week, he'll wrap up the two-part retrospective with a few more tracks from the collection.
Bruce, most known for his work with electric three-piece Cream, enjoyed an illustrious career of collaborations and solo work until his death in 2014. Willpower marked not just the halfway point, but masterfully captures both Bruce's personal appeal as well as those important collaborations with other important musics. Clapton, anyone?
Called a "through, representative introduction" to Bruce's work, two of the album's 17 tracks feature Cream tracks and two others feature ol' Slowhand himself. The rest are culled from Tailor and the three or four solo collections he recorded in its wake.
• Tommy will wrap up the day with the fifth and final studio album from American folk rock singer/songwriter Jim Croce.
After several years performing with his wife playing the club and college circuit, Croce finally broke through as a solo artist with the single, "Time in a Bottle", in 1972. He had just signed a three-record contract with ABC Records, and after quickly pumping out the second one in early 1973 – Life and Times, which featured hit single "Bad, Bad Leroy Brown" – Croce began work on I Got a Name.
The album was completed in September, but he would never see it released. Croce died in a plane crash after a performance in Louisiana at the age of 30, one week after I Got a Name was a wrap.
The album, released in December of that year, included three hits: "Workin' at the Car Wash Blues", "I'll Have to Say I Love You in a Song" and the title track, which had been previously released as the theme song to film "The Last American Hero".
Finally, it's Friday! It's Vinally Friday, all day on the Trail 103.3.
-Zeke Campfield
Filed Under: News Tagged With: Jack Bruce, Jim Croce, Nathaniel Zeke Campfield, Rocky Horror Picture Show, trail, Trail 103.3, vinally friday, Zeke Campfield


Ideal for small hatches and lofts with minimal storage space as these ladders close and store within the confines of the hatch. Available in two size options 2.6m or 2.9m floor to ceiling heights. Each model is adjustable to 3 different heights for perfect alignment when installing. Manufactured from clean anodized aluminium and featuring wide comfortable treads, these ladders are the latest and most popular addition to our loft ladder range.
The New Zarges Telescopic Loft Ladder introduces 21st century technology to the loft ladder market. ..
The New Zarges Telescopic Loft Ladder introduces 21st century technology to the loft ladde..
The New Youngman Telescopic Loft Ladder introduces 21st century technology to the loft ladder market..


Do you have any friends, relatives or acquaintances working for our Company?
I certify that I have not purposely withheld any information that might adversely affect my chances for hiring.
grounds for rejection of application or, if I am employed by this company, terms for my immediate expulsion from the company.
by either me or the company at any time either with or without prior notice.
experiences with them, without giving me prior notice of such disclosure. In addition, I release the company, my former employers & all other persons, corporations, partnerships & associations from any & all claims, demands or liabilities arising out of or in any way related to such examination or revelation.


text:
Upsiide
The Most Beloved Dumplings & Curries in 2022
Have you ever tried a new dish, and something about the flavour or smell instantly sent you back to your childhood? It might be the rhubarb pie that you used to have every Christmas. Or the ramen soup that your mom cooked when you were sick. Or the empanadas that you and your granddad made every weekend when you were a kid.
This is the power of food: it connects us to our past and culture, wherever we come from. Conversely, food also connected us to other people's cultures. In fact, different international foods have become so widely adopted and enjoyed that they've merged into new cuisines entirely that take inspiration from a variety of cultures.
This was the inspiration for our latest study, supported by Dig's Diversity & Inclusion Committee. We ran a survey using Dig's automated research platform Upsiide. The study was run with 1000 people in Canada and the USA to understand what cultural foods mean to them, and why they try foods from different cuisines.
We also leveraged Upsiide to test different types of Dumplings and Curries - foods much beloved by Dig employees themselves. After testing 20 different variations of dumplings and curries, we discovered which ones people like most and why they love them.
These insights helped us create a completely original menu for an aspirational Dig Café that contains dumplings and curries that have the most potential in-market.
Before we dive in, it's important to understand the methodology we used to assess the potential of these dumplings and curries. Let's run through the different scores on the Upsiide platform:
Upsiide's Interest Score is the proportion of people who liked an idea (in this case, dumplings and curries) and is expressed as a percentage. When respondents like two ideas, they are asked to trade-off between them, picking a favourite - which generates the Trade-off Score (often referred to as Initial Commitment). Finally, the Upsiide Score is based on a combination of the Interest Score and the Trade-off Score - it's an absolute score that's been calibrated to predict the performance in-market.
Now, it's time to dig in to our findings!
Insight #1: People's desire to stay connected to their culture drives their food choices.
We asked consumers why they eat foods from their culture. The options they had to choose from can be divided into two categories:
Practical reasons - e.g. health, accessibility, ease
Cultural reasons - familiarity with ingredients, pride of belonging to one culture, and connection to family
Overall, we discovered that the main reasons consumers like to eat their own cultural food is because of a sense of belonging and heritage. 65% of respondents cited cultural reasons like nostalgia for childhood/family and feeling a connection to their roots as the reasons they eat food from their own culture.
But what happens when we start dissecting the results based on ethnicity? Let's have a look at Canadians and Americans that identified themselves as Caucasian. While many stated that food of their own cultural background reminded them of childhood (59%), we also see that they preferred those foods because they are easier to find than others (38%) and because they are cheap[er] to buy or make (35%).
When we look at those respondents that self-identify as other ethnicities, we notice that cultural reasons significantly overpower practical reasons. Only 26% eat their own cultural food because it's cheaper to buy or make and 23% because it's better on their digestive system. In contrast, 60% eat foods that are typical of their cultural background to feel connected to their roots, and 56% because they prefer the taste of their own cultural foods over other foods.
What does this data tell us?
Nostalgia is the main driver for people to eat foods from their own cultural background. If a restaurant knows their consumer base is diverse and consist of people who identify with different backgrounds, it's best to offer cultural staples or popular dishes that tap into that nostalgia and sense of belonging.
Insight #2: Dish familiarity affects people's choice of dumplings and curries
We discovered that different ethnicities had different preferences for dumplings and curries.
Looking at the dumplings results, we see that Guotie/Potstickers and Wontons were the most popular among all audience groups, garnering Upsiide scores of 77 and 75 respectively. This could be because these two dumpling dishes are generally well known in Canada and the US, so consumers are likely to have been exposed to them more than other types of dumplings.
When we look at Caucasians, these dumplings remain the most popular: Wontons have an Upsiide score of 78 and Guotie/Potstickers is 77. In contrast, Har Gow was one of the lowest ranking dumplings with an Upsiide score of 58.
But as we filter down to people who self-identified as Chinese or Asian, the results change drastically. Chinese Canadians still prefer Guotie/Potstickers, but they feel the same way about Shumai and Har Gow/Shrimp Dumplings (staple dim sum dishes!) - all three types of dumplings got an Upsiide score of 81. Asian Americans like Guotie/Potstickers (83), Baozi/Steamed Bun (81) and Tangbao/Soup Dumplings (79).
We believe Har Gow/Shrimp Dumplings, Shumai, Baozi/Steamed Bun and Tangbao/Soup Dumplings share high popularity among Asian-Americans and Chinese Canadians, likely because these sub-groups have been introduced to a wider variety of dumplings than Caucasian consumers.
This is especially apparent when we look at the Idea Split section of our study. Upsiide's Idea Split feature allowed us to assess dumplings and curries against specific attributes and discover which items people found most and least appetizing (and why).
Caucasians in Canada found Har Gow/Shrimp Dumplings least appealing and least tasty, whereas Chinese Canadians people thought the opposite. Familiarity with more ingredients and dishes likely allowed Asian American and Chinese Canadian consumers to choose beyond Wontons and Guotie/Potstickers.
Preparation style also differed between consumer groups. Caucasian consumers were more attracted to fried options like Guotie/Potstickers, whereas Asian American and Chinese Canadian consumers preferred boiled and steamed dumplings like Har Gow/Shrimp Dumplings and Baozi/Steamed Bun. Inclination towards fried products is consistent with our previous studies in Canada and the US.
Curries:
The results aren't as black and white when we look at curries. Consumers across all audience groups were generally more attracted to Chicken Tikka Masala (Upsiide score of 76) and Butter Chicken (Upsiide Score of 72).
And this trend continues when we look at specific ethnic groups. Caucasians and South Asians in Canada and the US always chose those two curries over others, making these dishes absolute favourites among both groups.
So, what's the lesson here?
Restaurants and food providers should be thoughtful about who their ideal customer is; they don't need to rely exclusively on familiarity with dishes. After all, 58% of respondents stated that they eat foods from different cultures because they feel adventurous or like to switch things up.
Insight #3: The perfect restaurant menu should contain both mainstream and niche dishes
Welcome to Dig Café. While this restaurant is entirely fictional, it's our take on the optimal menu of dumplings and curries based on our research.
To identify the dumplings and curries that are likely to convert the most diners, we worked with Dig's analytics to model Total Unduplicated Reach and Frequency (TURF). TURF tells us the percentage of customers that a product can potentially reach, and identifies the combination of menu items that reaches the most customers.
Here's what came back:
What the chart shows is which dumplings and curries can, in combination, bring in the most customers. For instance, if Dig Café sells Chicken Tikka Masala, we'll be able to capture 69% of the market. But if we also add Guotie/Potstickers on the menu, we're likely to increase this potential to 84%. The percentage of customers reached increases as we add more menu items, until the results slowly plateau.
And the combination of items isn't limited to the above line-up. TURF modelling reveals 5 different product mixes that have the potential to reach a similar percentage of people. If we look at different combinations of dumplings and curries in total, we can see 3 winning items that are likely to capture the most consumers - Chicken Tikka Masala, Guotie/Potstickers and Har Gow/Shrimp Dumplings.
A restaurant can then choose the remaining 2 items based on their business capabilities - e.g. access to ingredients, supplier availability, etc. For instance, if the restaurant chooses to sell Wontons and Baozi and then realizes that access to Baozis ingredients are difficult to get their hands on, they can move on to the next best option, which is Pasanda.
What the restaurant can learn from this is that it's not the best practice to only choose the best-performing dishes for a new menu because those can only capture so many consumers. It's better to have a variety of dishes that are both general crowd pleasers and dishes that cater to different taste preferences.
To show how TURF can be used in action, we created a menu for our fictional Dig Café.
This menu includes items that almost everyone will find interesting. Because we want to offer a variety of dumplings and curries that have different flavours and textures, we went with the combination number 3 from the TURF table.
And to make things more fun and to pay homage to some of the things we do at Dig, we also included popular cocktails that Dig's Cocktail & Mixology Club made for us in the past. Honestly, what a great way to complete your evening of eating delicious dumplings and curries!
While this study showcased some of Dig's and Upsiide's research capabilities, we also aimed to take a D&I angle and pay homage to some of the largest cultural groups we have at Dig. We believe food is one of the things that make our cultures different and unique, but it also is one of the things that unites us.
Here's Why The Respondent Experience Needs to Change
With more agile and AI-powered platforms getting data, at a low cost and in hours has given companies more opportunities to make consumer-centric decisions
Here's Why You Need to Scale Research Expertise to Automate DIY Research
It's not DIY research vs automated research. The real sweet spot lies in automated research that flexes to the unique needs of your business and research team.
COVID-19 Was A Surprise — What Comes Next For Business Is Predictable
What is pretty clear about Covid-19 is that we've already crossed the line in-terms of being able to forecast a global recession.
The Elusive Nature of Neural Nets — Part Two: Mother Knows Best
Why you should start thinking of AI models as peculiar children.
Whether you've got a specific project in mind, or you'd like to learn more - we'd love to hear from you.
Dig Insights.
372 Bay Street, 16th Floor
Toronto, Ontario M5H 2W9
500 W Madison St. Suite 1000
E - Email info@diginsights.com
T - Telephone +1 866-496-4344
SaaS Expertise
Digital Eco-Systems
Mobile Diaries
Virtual Market
Portfolio Modeling
Shop-Alongs
Consumer Journey Mapping
Usage & Attitudes
We built Upsiide, an innovation insights platform, to help researchers and marketers screen ideas, assess concepts, and innovate more effectively.
Visit Upsiide
© Copyright 2022. Dig Insights. All rights reserved.
Transcipt text goes here Test link;


text:
Buy XRP
Dogecoin Wallet
Tron (TRX) Wallet
Hardware Wallet Review
What is Ripple?
What is Dogecoin?
What is Tron?
Stellar Lumens: SDF COO wants to build a fiat anchor in every country
By Reynaldo	 30. March 2021 No Comments
Source: Wit Olszewski - Shutterstock
SDF has the vision to build a bridge between Stellar Lumens and all fiat currencies in the world.
Stellar has been built as a payment use case-focused platform that differentiates it from Ethereum and other blockchains.
Stellar Development Foundation (SDF) COO Jason Chlipala gave an interview to discuss some of the most relevant points for the platform and the crypto industry. Highlighting that SDF's mission is to be a support for increasing access to the global financial system, he stated that Stellar Lumens is a platform for connecting and opening up financial structures.
On the main use cases, Chlipala said Stellar is focused on payments and in its native functions, such as asset creation and tokenization of regulated assets. Currently, SDF is working on developing bridges between the "Stellar world" and the non-Stellar world, these entities are known as "anchors".
Cooperations built on Stellar Lumens
One of the most important anchors for the SDF was deployed in early February this year. As a result of a cooperation with CENTRE consortium, Stellar became the third blockchain to host stablecoin USD Coin (USDC), along with Ethereum and Algorand. Chlipala stated:
We are focused on building that network, eventually the goal is to have anchors in all currencies. So every country you can imagine has an anchor. So if you then want to convert your fiat money into a Stellar asset, you can do that.
Delving into other Stellar Lumens features, Chlipala stated they have set out not to make Stellar an "answer for everything," but a solution for specific cases. The executive added:
In the realm of payments or in the realm of digitizing regulated assets, Stellar is great. That's precisely because it's narrow, because it has a focus. That's something that really attracted me to the technology. I think that will make it successful.
Chlipala then turned to the partnership with the Ukrainian Ministry for Digital Transformation. Together with its partner, SDF is building a national strategy to create policies and a framework focused on digital assets and the possible launch of a CBDC. SDF's COO revealed that they are in talks with other central banks and governments to implement a similar arrangement. Chlipala added:
I am impressed by the vision and foresight the Ministry is showing in these areas. Ukraine is a very interesting country for blockchain in general and cryptocurrencies, it is a major remittance corridor. It is very well positioned to develop policies on digital assets (…). Stellar was thinking about stablecoins before the term existed.
Stellar Lumens XLM
Shiba Inu and CoinMarketCap team up to solve "wormhole" addresses issue
U.S traders account for the lion's share of Bitcoin trading: Arcane Research
A $69B bet on the metaverse? Microsoft buys Activision Blizzard
Crypto investors need to pay close attention to Cardano in 2022, here's why
About us and additional Info
Crypto News Flash is your number one source for the latest news and information from the world of cryptocurrencies.
*= Affiliate-Link
XRP Price
Bitcoin Cash Price
IOTA Price
Buy Cryptocurrencies
Buy IOTA
Buy Monero
Risk warning and disclaimer: The contents of this website are intended solely for the entertainment and information of readers and do not provide investment advice or a recommendation within the context of the Securities Trading Act. The content of this website solely reflects the subjective and personal opinion of the authors. Readers are requested to form their own opinions on the contents of this website and to seek professional and independent advice before making concrete investment decisions. The information found on this site does not contain any information or messages, but is intended solely for information and personal use. None of the information shown constitutes an offer to buy or sell futures contracts, securities, options, CFDs, other derivatives or cryptocurrencies. Any opinions provided, including e-mails, live chat, SMS or other forms of communication across social media networks do not constitute a suitable basis for an investment decision. You alone bear the risk for your investment decisions. Read more!


YOU'VE COME TO THE RIGHT SITE. WE ARE PROMOTIONAL PRODUCTS EXPERTS WHO ARE COMMITTED TO YOUR SUCCESS.Whether you are looking for a specific item or just browsing for ideas, our site is your one-stop shopping source. From fun items to the traditional, you can easily search for some of the hottest items on the market, and we are here for you 24 hours a day - 7 days a week.


We all survived the great ~6% pullback of 2013! Momentum remains bullish as markets continue to focus on central banks and the timing of QE exit. Even with earnings season in full swing, the syllable-by-syllable analysis of Bernanke's speech on the history of the Fed received more attention than the earnings of the world's premier financial franchise. Luckily for the bulls, the focus of the speech was on keeping rates low for an extended period of time (LEPT policy).
An overall defensive week despite the big run higher. Utilities, consumer staples, and healthcare led the charge. Is it just me or has every bull run in recent memory been fueled with toe-in-the-water buying of defensive sectors? Lagging sectors this week were industrials, energy, and technology. Large cap tech can't seem to get out of its own way. Growth orientated technology had an amazing week.
I mentioned that a break down in breadth would be a warning sign for the market last week. Breadth didn't break down, but this and other indicators are flashing divergence. I'd like to see it back in sync with the market and return to all-time highs. I also recognize that it is probably prudent to give these indicators some time to come into line.
On fatherhood: In general, I'm sure I worry too much about life. I always try and be mindful that every experience in life is a two-sided coin. No matter how great anything seems at the time there is always nuance and perspective to be gained. Most of the advice you get on being a new father centers around the negatives, like the fact that you will never sleep again (and yes, they're right). I think this is because fatherhood is such an individual experience that it's difficult to enunciate the great things about being a dad. Two weeks ago my wife gave birth to a beautiful baby girl. The love I feel for my new baby girl is the only 100% pure emotion I have ever felt. There is no shade of grey, nuance or perspective. It is a single-sided coin. Pure upside. It's an amazing feeling.


text:
Barcelona Pro League Soccer Kits 2023
Download the latest Barcelona Pro League Soccer Kits 2023. Barcelona FC is a very trendy football club in Europe. It is one of the beloved clubs in Spain. Barcelona FC is a very familiar Soccer club in La Liga. Barcelona FC wins numerous La Liga matches. It is one of the seasoned football clubs from Barcelona, Spain that first join the professional leagues.
Barcelona Kits 2023 Pro League Soccer
This club was established in 1899. The nickname of the club is Barça. The short name of the team is FCB. The chairman of the club is Joan Laporta. Xavi is serving as the Manager and making team much better with his managerial skills. Sergio Busquets is the current captain and he is leading the team from the front. The Ground name of the club is Camp Nou it is one of the big stadiums in the country. Everybody loves Barcelona FC which plays pro league soccer and wants to customize the kit of Barcelona football club.
Barcelona FC PLS Kits 2023
You can download the customized kits of Barcelona FC pro league soccer kits 512×512 URL. Pro League Soccer kit 2023 of Barcelona FC is unique and attractive. There are 3 types of kits home, away, and third kit.
URL: https://i.imgur.com/FZePqt7.png
URL: https://i.imgur.com/98VFJo4.png
URL: https://i.imgur.com/OjZ11UC.png
URL: https://i.imgur.com/TrVndf5.png
URL: https://i.imgur.com/aMjOkRD.png
Barcelona FC Logo 512×512 URL
URL: https://i.imgur.com/ySz79Er.png
Download the Barcelona FC Logo 512×512 URL. The logo is simple but attractive. Different colors are used in the logo like red, blue, yellow, and white. There is a soccer ball of yellow color at the bottom of the logo. You can also get other teams Pro League Soccer Kits And Logos and change kits and logos very easily.


Born close to two of Kenya's best National Parks, Cosmas Maluki developed a passion for wildlife at a young age. He studied tourism, graduating with top marks, before joining A&K's guide training programme. Cosmas has been working with A&K as a professional safari guide since 1994, and his knowledge, language skills and warm disposition make him a favourite with our clients.
Cosmas Maluki grew up in Kenya's Kitui County, an area en route to the popular Amboseli and Tsavo National Parks. With such amazing wildlife on his doorstep, and a safari guide as his neighbour, it's no wonder he developed a love of animals early on.
Cosmas went on to study tourism, graduating top of his class and earning himself a spot on A&K's guide training programme. He joined the A&K team as a professional safari guide in 1994, and has been sharing his knowledge and passion with our clients ever since.


Hazel Park Harness Raceway in Hazel Park, Michigan, has reportedly set out body-gripping traps, apparently in an effort to kill groundhogs. These devices are exceptionally cruel, inflicting immense suffering while terrified victims die of slow suffocation. Such traps are also indiscriminate, posing risks to "nontarget" animals, including protected wildlife species and even companion animals. In fact, we're told that a kitten was recently caught and gruesomely killed [graphic photo] in a trap at this facility. PETA urged Hazel Park Harness Raceway to remove all such traps that may be set on its property, but to no apparent avail. Your voice is needed!
Please contact raceway officials and urge them to forgo cruel trapping and instead employ humane and effective wildlife deterrent measures.
It has come to my attention that Hazel Park Harness Raceway in Hazel Park, Michigan, has reportedly set out body-gripping traps, apparently in an effort to kill groundhogs. Please remove these barbaric devices and instead employ humane and effective wildlife deterrent measures.
Body-gripping traps are exceptionally cruel, inflicting immense suffering while victims die of slow suffocation, all the while experiencing extreme terror and pain. Such traps are also indiscriminate, posing risks to "nontarget" animals, including protected wildlife species and even companion animals. In fact, I am told that a kitten was recently caught and gruesomely killed in a trap at this facility.
for any being to expire.
It's amazingly perfect, thank you, hon.
let us hope that the powers that pee listen before there is more suffering!
E-mail sent and action shared. Re-blogged on "Wolf Is My Soul".


text:
This page lists the documents in the Library according to the first letter in the document title. To display a list of documents starting with a character (e.g. A) click on the corresponding letter. Publications are available in HTML, PDF , DOC or XLS format. Click on the corresponding title to open the publication. The PDF icon located on the cover page of a publication represents that the publication is available only in PDF format. If the PDF icon is located near the title of the publication it means the document is available in both HTML and PDF formats.
All - Arabic - Chinese - English - French - Russian - Spanish - Albanian - Amharic - Bengali - Bulgarian - Croatian - Czech - Danish - Dutch - Estonian - Finnish - German - Greek - Hindi - Hungarian - Indonesian - Italian - Japanese - Korean - Kyrgyzstan - Latvian - Lithuanian - Macedonian - Mongolian - Norwegian - Persian - Polish - Portuguese - Romanian - Serbian - Sinhalese - Slovak - Slovenian - Swedish - Tajik - Tamil - Thai - Ukrainian - Vietnamese
All - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z - 0-9
3926 documents on 79 pages
10 Stories that Mattered in Access to Medicines in 2011 - Médecins Sans Frontières (MSF Access Campaign)
Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Financing
Medicine Access and Rational Use > Pricing
Médecins sans Frontières (MSF)
11th International Conference of Drug Regulatory Authorities - Proceedings
Spanish Agency for Medicines and Health Products
11th International Conference of Drug Regulatory Authorities - Progress Report and Recommendations
12th International Conference of Drug Regulatory Authorities - Recommendations
1st World Conference on Access to Medical Products and International Laws for Trade and Health in the Context of the 2030 Agenda for Sustainable Development. Final report, 21-23 November 2017, New Delhi, India.
WHO Country Office in India
India - Ministry of Health & Family Welfare (MOHFW)
Public health, innovation and intellectual property rights: report of the Commission on Intellectual Property Rights, Innovation and Public Health
Health, Essential Medicines, Human Rights & National Constitutions
Intellectual Property and Access to Medicines: Papers and Perspectives
Access to Essential Medicines in National Constitutions
Local Production for Access to Medical Products: Developing a Framework to Improve Public Health
A Lifeline to Treatment: The Role of Indian Generic Manufacturers in Supplying Antiretroviral Medicines to Developing Countries
Intellectual Property and Access to Medicines. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 3)
Promoting Access to Medical Technologies and Innovation. Intersections Between Public Health, Intellectual Property and Trade
Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination. Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination
Global Action Plan on Antimicrobial Resistance (2015)
Health in 2015: from MDGs, Millennium Development Goals to SDGs, Sustainable Development Goals
An R&D Blueprint for Action to Prevent Epidemics. Funding & Coordination Models for Preparedness and Response. May 2016 (Being ready for the next epidemic: How to improve R&D funding for preparedness and response to emerging pathogens. An exploration of different funding and coordination models in the framework of the WHO R&D Blueprint for action to prevent epidemics)
Towards Access 2030. (Essential Medicines for Universal Health Coverage - Comment. The Lancet Commission on Essential Medicines Policies)
Report of the United Nations Secretary-General's High-Level Panel on Access to Medicines. Promoting innovation and access to health technologies. September 2016
Essential Medicines for Universal Health Coverage. (The Lancet Commission on Essential Medicines Policies)
A Human Rights-based Approach to the Reimbursement of Expensive Medicines. (Bull World Health Organ 2016;94:935–936)
Essential Medicines in National Constitutions: Progress Since 2008
Towards Access 2030. WHO Medicines and Health Products Programme Strategic Framework 2016 - 2030
Report on the Fair Pricing Forum 2017. Amsterdam, The Netherlands, 11 May 2017
Medicine Procurement and the Use of Flexibilities in the Agreement on Trade-related Aspects of Intellectual Property Rights, 2001–2016. (Bull World Health Organ 2018;96:185–193)
Access Observatory 2018 Report. Results and Reflections on Year One
http://www.who.int/medicines/access_use/en/http://www.who.int/medicines/regulation/en/http://www.who.int/medicines/areas/human_rights/en/
2009 FIP Global Pharmacy Workforce Report
Medicine Programme Coordination > Human Resources for Pharmaceutical Sector
International Pharmaceutical Federation (FIP)
https://www.fip.org
https://www.fip.org/humanresources
2013 FIPEd Global Education Report
http://www.fip.org/www/index.php?page=educationreports
2015 Global Survey on Health Technology Assessment by National Authorities. Main Findings
Health Technology Assessment > Evidence-based Medicine
Health Technology Assessment > Policies
Health Technology Assessment > Assessment Results
Health Technology Assessment > Cost Effectiveness
Health Technology Assessment > Clinical Effectiveness
Measuring Medicine Prices, Availability, Affordability and Price Components - 2nd Edition
WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations - Guide for Coordinators and Data Collectors
Options for Financing and Optimizing Medicines in Resource-poor Countries. Discussion Paper Number 7 - 2010
The Judgement Process in Evidence-based Medicine and Health Technology Assessment
The World Health Report 2010. Health Systems Financing: The Path to Universal Coverage
Health Technology Assessment Methodologies for Developing Countries
Clinical Evidence for Medical Devices: Regulatory Processes Focusing on Europe and the United States of America: Background Paper 03, August 2010
Sound Choices: Enhancing Capacity for Evidence-Informed Health Policy
Making Fair Choices on the Path to Universal Health Coverage. Final Report of the WHO Consultative Group on Equity and Universal Health Coverage
WHA67.23 - Health Intervention and Technology Assessment in Support of Universal Health Coverage. WHA Resolution; Sixty-seventh World Health Assembly, 2014
Health Technology Assessment of Medical Devices. (WHO Medical Device Technical Series)
Medicines in Health Systems: Advancing Access, Affordability and Appropriate Use
Access to New Medicines in Europe: Technical Review of Policy Initiatives and Opportunities for Collaboration and Research
Developing an Approach for Using Health Technology Assessments in Reimbursement Systems for Medical Products. Geneva, Switzerland, July 20-21, 2015
Health Technology Assessment and Health Policy-making in Europe. Current Status, Challenges and Potential. Observatory Studies Series No 14
http://www.who.int/health-technology-assessment/en/http://www.who.int/medical_devices/en/http://www.who.int/medicines/areas/access/en/
The 2016 Access to Medicine Index - Methodology 2015
Medicine Information and Evidence for Policy > Monitoring and Evaluation
Access to Medicine Foundation
Big Pharma and Social Responsibility — The Access to Medicine Index
Access to Medicine Index - Methodology Report 2013 for the 2014 Access to Medicine Index
The Access to Medicine Index 2014
Rapid Access to Investigational Vaccines: an Analysis of Access Provisions. Vaccine Pipeline Analysis, 30 September 2015
Access to Medicine Index 2016
Access to Medicine Index 2018 - Methodology Report
http://www.accesstomedicineindex.org/http://www.who.int/medicines/areas/policy/en/
25 Questions and Answers on Health and Human Rights [Arabic] [Chinese] [French] [Russian] [Spanish]
IPR, Innovation, Human Rights and Access to Drugs - An Annotated Bibliography - Health Economics and Drugs Series No. 014
Essential Medicines and Human Rights: What Can They Learn From Each Other?
Is Access to Essential Medicines As Part Of The Fulfilment of the Right to Health Enforceable Through the Courts?
The World Medicines Situation 2011 - Access to Essential Medicines as Part of the Right to Health
A Right to Health
Respecting the Right to Access to Medicines: Implications of the UN Guiding Principles on Business and Human Rights for the Pharmaceutical Industry
Health Technologies and Pharmaceuticals Division of Health Systems and Public Health. Annual Report 2012, WHO/Europe. Access to essential, quality medicines and health technologies is a fundamental part of every person's right to health
The Right to Health and Medicines: The Case of Recent Negotiations on the Global Strategy on Public Health, Innovation and Intellectual Property. (The South Centre - Research Papers 35, January 2011)
The Doha Declaration Ten Years on and Its Impact on Access to Medicines and the Right to Health, 2011. Discussion Paper, UNDP
http://www.who.int/hhr/en/http://www.who.int/medicines/areas/human_rights/en/
25 Years of the WHO Essential Medicines Lists: Progress and Challenges
Ford, Nathan; Gray, Andy; Laing, Richard; 't Hoen, Ellen; Waning, Brenda
2nd Biennial Scientific Conference on Medicines Regulation in Africa. Addis Ababa, Ethiopia, 30th November to 1st December 2015 - Book of Abstracts. Conference Theme: Regulatory Systems Strengthening for advancing Research, Innovation and Local Pharmaceutical Production in Africa
NEPAD - The New Partnership for Africa's Development / African Union (AU)
World Health Organization - Regional Office for Africa (WHO/AFRO)
Assessment of Medicines Regulatory Systems in Sub-Saharan African Countries. An Overview of Findings from 26 Assessment Reports
First African Medicines Regulatory Authorities Conference - Final Report. Addis Ababa, Ethiopia, 31 October – 3 November 2005
Impact of Regulatory Requirements on Medicine Registration in African Countries – Perceptions and Experiences of Pharmaceutical Companies in South Africa - Southern Med Review Vol 5 Issue 1 July 2012
Guidelines for Registration of Traditional Medicines in the WHO African Region
African Medicines Registration Harmonisation (AMRH) Initiative: Summary, Status and Future Plans. The New Partnership for Africa's Development (NEPAD) & the World Health Organization (WHO)
WHO Support for Medicines Regulatory Harmonization in Africa: Focus on East African Community. (WHO Drug Information Vol. 28 No. 1, 2014)
Pro-generics Policies and the Backlog in Medicines Registration in South Africa: Implications for Access to Essential and Affordable Medicines
Meeting of the NEPAD Regional Centers of Regulatory Excellence (RCORES) in Pharmacovigilance. May 14–15, 2015, Accra, Ghana. Report of Proceedings
Situation Analysis Study on Medicines Registration Harmonization in Africa. Final Report for the East African Community /EAC), November 2010
First Biennial Scientific Conference on Medicines Regulation in Africa. Johannesburg, South Africa, 2-3 December, 2013 - Conference Report. Conference Theme: Building Partnerships for Sustainable Capacity Development in Medicines Regulation in Africa
First Biennial Scientific Conference on Medicines Regulation in Africa. Johannesburg, Afrique du Sud, 2–3 December 2013 - Book of Abstracts. Conference Theme: Building Partnerships for Sustainable Capacity Development in Medicines Regulation in Africa
http://amrh.org/http://www.nepad.org/http://www.au.int/en/commissionhttp://www.eac.int/http://www.afro.who.int/en/clusters-a-programmes/hss/essential-medicines/edm-publications.htmlhttp://www.who.int/medicines/areas/quality_safety/regulation_legislation/en/
Africa (AFRO); EAC East African Community
3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015 - Abstract Poster Book
WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies
Pharmaceuticals: Cost cointainment, Pricing, Reimbursement. World Bank, HNP Brief #7
Pharmaceutical Pricing and Reimbursement Information (PPRI), Austria, September 2008
Pharmaceutical Policies in European Countries in Response to the Global Financial Crisis - Southern Med Review Vol 4 Issue 2 Dec 2011
Pharmaceutical Pricing Policy. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 9)
Pharmaceutical Pricing Policies in a Global Market. OECD Health Policy Studies
Cost-containment Policies in Public Pharmaceutical Spending in the EU. Economic Papers 461. September 2012 (European Economy/European Commission)
The World Medicines Situation 2011 (Chapters Currently Available)
Pharma Futures. Pathways to Value: Pharma in a Changing World. PharmaFutures Global Conclusions
Priority Medicines for Europe and the World 2013 Update (EMP Research Series No. 38)
Priority Medicines for Europe and the World 2013 Update. Background Paper 8 - New Approaches to Promoting Innovation. BP 8.3 - Pricing and Reimbursement Policies: Impacts on Innovation
Pharmaceutical Policy and the Effects of the Economic Crisis: Estonia
Pharmaceutical Policy and the Effects of the Economic Crisis: Latvia
Pharmaceutical Policy and the Effects of the Economic Crisis: Lithuania
What Do We Really Know about Reference Pricing for Pharmaceuticals? Evidence from a Systematic Review of the Literature
WHO Guideline on Country Pharmaceutical Pricing Policies
Value in Pharmaceutical Pricing. OECD Health Working Papers No. 63
Effect of the Economic Recession on Pharmaceutical Policy and Medicine Sales in Eight European Countries
WHO Essential Medicines Policies and Use in Developing and Transitional Countries: An Analysis of Reported Policy Implementation and Medicines Use Surveys
Using the WHO Essential Medicines List to Assess the Appropriateness of Insurance Coverage Decisions: A Case Study of the Croatian National Medicine Reimbursement List
Abstracts from the 3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015
3rd International PPRI Conference 2015: Pharmaceutical Pricing and Reimbursement Policies: Challenges Beyond the Financial Crisis. Vienna, Austria, 12-13 October 2015 - Country Poster Book
http://whocc.goeg.at/Conference2015/Programmehttp://www.who.int/medicines/access/en/http://www.haiweb.org/medicineprices/http://www.joppp.org/
A39/13 - Who's Revised Drug Strategy. Report by the Director-general, Thirty-ninth World Health Assembly, 1986 [French] [Spanish]
WHA54.11 - WHO Medicines Strategy. WHA Resolution; Fifty-fourth World Health Assembly, 2001
A54/17 - Revised Drug Strategy. Report by the Secretariat, Fifty-fourth World Health Assembly, 2001
The Rational Use of Drugs - Report of the Conference of Experts, Nairobi 25-29 November 1985
WHA52.19 - Revised Drug Strategy. WHA Resolution; Fifty-second World Health Assembly, 1999
WHA49.14 - Revised Drug Strategy. WHA Resolution; Forty-ninth World Health Assembly, 1996
WHA37.33 - Rational Use of Drug. WHA Resolution; Thirty-seventh World Health Assembly, 1984
http://www.who.int/governance/en/http://www.who.int/medicines/en/http://apps.who.int/medicinedocs/permalinks/open/periodicals/who-publications/all/english/world-health-assembly-wha-and-executive-board-eb-resolutions-and-documentation
A51/9 - Emerging and Other Communicable Diseases: Antimicrobial Resistance. Report by the Secretariat, Fifty-first World Health Assembly, 1998
Medicine Access and Rational Use > Antimicrobial Drug Resistance
Community-Based Surveillance of Antimicrobial Use and Resistance in Resource-Constrained Settings. Report on Five Pilot Projects - EDM Research Series No. 037
WHA51.17 - Emerging and Other Communicable Diseases: Antimicrobial Resistance. WHA Resolution; Fifty-first World Health Assembly, 1998
A58/14 - Antimicrobial Resistance: a Threat to Global Health Security. Rational Use of Medicines by Prescribers and Patients. Report by the Secretariat, Fifty-eighth World Health Assembly, 2005
WHA 2007. A60/28 - Progress Reports on Technical and Health Matters. Improving the containment of antimicrobial resistance (resolution WHA58). Report by the Secretariat, Sixtieth World Health Assembly, 2007
WHA58.27 - Improving the Containment of Antimicrobial Resistance. WHA resolution; Fifty-eighth World Health Assembly, 2005
WHO Global Strategy for Containment of Antimicrobial Resistance
The WHO Policy Package to Combat Antimicrobial Resistance
The Evolving Threat of Antimicrobial Resistance: Options for Action
Antimicrobial Resistance. Resolutions of the World Health Assembly and WHO Regional Committee for South-East Asia. Use Antibiotics Rationally
Regional Strategy on Prevention and Containment of Antimicrobial Resistance 2010-2015
Priority Medicines for Europe and the World 2013 Update. Background Paper 6 - Priority Diseases and Reasons for Inclusion. BP 6.01 - Antimicrobial Resistance
Antimicrobial Resistance: Global Report on Surveillance, 2014
WHA67.25 - Antimicrobial Resistance. WHA resolution; Sixty-seventh World Health Assembly, 2014
WHA68.7 - Global Action Plan on Antimicrobial Resistance. WHA Resolution; Sixty-eighth World Health Assembly, 2015
Antimicrobial Resistance in the Western Pacific Region. A Review of Surveillance and Health Systems Response
Central Asian and Eastern European Surveillance of Antimicrobial Resistance. Annual Report 2016
Antimicrobial Resistance Surveillance in Europe. Annual Report of the European Antimicrobial Resistance Surveillance Network (Ears-net) 2014
http://www.who.int/governance/en/index.htmlhttp://www.who.int/antimicrobial-resistance/en/http://www.who.int/medicines/areas/rational_use/emp_amr/en/http://apps.who.int/medicinedocs/permalinks/open/subjects/all/all/english/medicine-access-and-rational-use/antimicrobial-drug-resistance
A54/17 - Revised Drug Strategy. Report by the Secretariat, Fifty-fourth World Health Assembly, 2001 [French] [Spanish]
A39/13 - Who's Revised Drug Strategy. Report by the Director-general, Thirty-ninth World Health Assembly, 1986
A54/9 - Global health security - epidemic alert and response. Report by the Secretariat, Fifty-fourth World Health Assembly, 2001
http://www.who.int/governance/en/index.htmlhttp://www.who.int/medicines/areas/rational_use/emp_amr/en/http://www.who.int/antimicrobial-resistance/en/http://apps.who.int/medicinedocs/permalinks/open/subjects/all/all/english/medicine-access-and-rational-use/antimicrobial-drug-resistance
A55/13 - Quality of Care: Patient Safety. Report by the Secretariat, World Health Assembly, 2002
Emergency and Essential Surgical Care > Surgical Safety
Emergency and Essential Surgical Care > Surgical Procedures
http://www.who.int/governance/en/index.htmlhttp://www.who.int/topics/patient_safety/en/http://www.who.int/medicines/en/
http://www.who.int/medicines/areas/rational_use/emp_amr/en/http://www.who.int/antimicrobial-resistance/en/http://apps.who.int/medicinedocs/permalinks/open/subjects/all/all/english/medicine-access-and-rational-usehttp://www.who.int/governance/en/index.html
A70/23 - Member State Mechanism on Substandard/Spurious/Falsely-labelled/Falsified/ Counterfeit Medical Products. Report by the Director-general. Seventieth World Health Assembly, 2017. (With A70/23 Add.1 - Review of the Member State Mechanism On Substandard/Spurious/Falsely-labelled/ Falsified/Counterfeit Medical Products) (with Appendix 1: Guidance on Developing a National Plan for Preventing, Detecting and Responding to Actions, Activities and Behaviours That Result in Substandard/Spurious/Falsely-labelled/Falsified/Counterfeit (Ssffc) Medical Products. Appendix 2: Available Authentication Technologies for the Prevention and Detection of (Ssffc) Medical Products. Appendix 3: Who Member State Mechanism on Substandard/Spurious/Falsely-labelled/Falsified/Counterfeit (Ssffc) Medical Products: Working Definitions) [Arabic] [Chinese] [French] [Russian] [Spanish]
Quality and Safety: Medicines > Counterfeit Medicines
Survey of the quality of antiretroviral medicines circulating in selected African countries
Counterfeit Drugs. Guidelines for the development of measures to combat counterfeit drugs
Counterfeit and Substandard Drugs in Myanmar and Viet Nam - Report of a Study Carried out in Cooperation with the Governments of Myanmar and Viet Nam - EDM Research Series N0. 029
Pharmaceuticals: Counterfeits, Sustandard Drugs and Drug Diversion. World Bank, HNP Brief #2
Survey of the Quality of Selected Antimalarial Medicines Circulating in Madagascar, Senegal, and Uganda
Combating Counterfeit, Falsified and Substandard Medicines: Defining the Way Forward? Chatham House Briefing Paper, November 2010
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
Report of the Situation of Counterfeit Medicines Based on Data Collection Tool. WHO Regions for Africa and Eastern Mediterranean
Lessons from Nigeria: The Fight Against Counterfeit Drugs in Africa
Survey of the Quality of Anti-tuberculosis Medicines Circulating in Selected Newly Independent States of the Former Soviet Union
Report on Countrywide Survey for Spurious Drugs - India, 2009
FIP Statement of Policy on Counterfeit Medicines
The Economic Impact of Counterfeiting and Piracy. OECD publications
WHA65.19 - Substandard/spurious/falsely-labelled/falsified/counterfeit medical products. (with annex: Member State mechanism on substandard/spurious/falsely-labelled/ falsified/counterfeit medical products. Goal, objectives and terms of reference . WHA resolution; Sixty-fifth World Health Assembly, 2012
Mechanism to Combat Substandard/Spurious/Falsely-labelled/ Falsified/Counterfeit Medical Products (WHO Drug Information, Vol 27, No. 1, 2013)
WHO Project for the Surveillance and Monitoring of SSFFC Medical Products
Public Health and Counterfeit Medicines: The Role of the World Health Organization
Task-Force Report on Parallel Importation, Counterfeits and Illegal Trade in Pharmaceuticals. Pharmacy and Poisons Board, MOH Kenya
Report of the Second Meeting of the Member State Mechanism on Substandard/spurious/falsely-labelled/falsified/counterfeit Medical Products. (A/MSM/2/6)
Addressing the Barriers to Effective Monitoring, Reporting and Containment of Spurious/Substandard/Falsely-labelled/ Falsified/Counterfeit Medical Products through Sustainable Multi-stakeholder Collaboration and Community/Consumer-based Interventions. A report prepared for the Medicines Transparency Alliance, Philippines
Survey of the Quality of Medicines Identified by the United Nations Commission on Life-saving Commodities for Women and Children. 2015
Survey of the Quality of Selected Antiretroviral Medicines Circulating in Five African Countries. (WHO Drug Information Vol. 31, No. 2, 2017)
A Study on the Public Health and Socioeconomic Impact of Substandard and Falsified Medical Products
WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products
http://www.who.int/medicines/regulation/ssffc/en/http://www.who.int/medicines/areas/quality_safety/quality_assurance/en/http://apps.who.int/gb/
Abbreviated Excel version of the Standard Treatment Guidelines and Essential Medicines List for South Africa. Primary Health Care Level. Sixth edition, 2018
South Africa - The National Department of Health, Pretoria
Standard Treatment Guidelines and Essential Medicines List for South Africa. Primary Health Care Level. Sixth edition, 2018
http://www.kznhealth.gov.za/edl.htmhttp://www.health.gov.za/http://www.who.int/selection_medicines/en/
The Ability of Select Sub-Saharan African Countries to Utilise Trips Flexibilities and Competition Law to Ensure a Sustainable Supply of Essential Medicines: A Study of Producing and Importing Countries
Public Health, Innovation, Intellectual Property and Trade > Intellectual Property (IP) and Trade
Avafia, Tenu; Berger, Jonathan; Hartzenberg, Trudi
Trade law centre for southern Africa (TRALAC)
United Nations Conference on Trade and Development (UNCTAD )
Africa (AFRO); Sub-Saharan Africa (SSA)
Abridged Prequalification Assessment - Prequalification of in Vitro Diagnostics
Diagnostics and Laboratory Technology > Evaluation of Diagnostics
Instructions for the completion of the pre-submission form - Prequalification of In Vitro Diagnostics
Pre-submission form - Prequalification of In Vitro Diagnostics
Eligibility criteria for WHO prequalification of in vitro diagnostics. Version 3. Geneva: World Health Organization; 2018 - Prequalification of in vitro diagnostics
Prequalification fees - Version 2 Geneva: World Health Organization; 2018 - Prequalification of in Vitro Diagnostics
Prequalification Assessment and Change Assessment Target Deadlines - Prequalification of in Vitro Diagnostics
Reportable Changes to a WHO Prequalified In Vitro Diagnostic Medical Device
Overview of the WHO Prequalification of in Vitro Diagnostics Assessment. Version 8. Geneva: World Health Organization; 2018 - WHO Prequalification of in Vitro Diagnostics
http://www.who.int/diagnostics_laboratory/en/http://www.who.int/diagnostics_laboratory/evaluations/en/http://www.who.int/medicines/regulation/prequalification/en/
Babar, Zaheer-Ud-Din; Vogler, Sabine; Zimmermann, Nina
Accelerated Stability Studies of Widely Used Pharmaceutical Substances Under Simulated Tropical Conditions
Accelerating access to essential medicines in the WHO South-East Asia Region: opportunities for greater engagement and better evidence. (WHO South-East Asia Journal of Public Health | September 2018)
Medicine Access and Rational Use > Controlled Medicines
Medicine Access and Rational Use > Supply Management
Singh, Poonam Khetrapal; Travis, Phyllida
World Health Organization - Regional Office for South-East Asia (WHO/SEARO)
Improving Access to Medicines in the South-East Asia Region: Progress, Challenges, Priorities
Pricing policies for generic medicines in Australia, New Zealand, the Republic of Korea and Singapore: patent expiry and influence on atorvastatin price. (WHO South-East Asia Journal of Public Health | September 2018)
Approaches to improving access to essential cancer medicines in the WHO South-East Asia Region. (WHO South-East Asia Journal of Public Health | September 2018)
Improving access to assistive technologies: challenges and solutions in low- and middle-income countries. (WHO South-East Asia Journal of Public Health | September 2018)
Addressing the threat of antibiotic resistance in Thailand: monitoring population knowledge and awareness. (WHO South-East Asia Journal of Public Health | September 2018)
Access to pain relief and essential opioids in the WHO South-East Asia Region: challenges in implementing drug reforms. (WHO South-East Asia Journal of Public Health | September 2018)
Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment. (WHO South-East Asia Journal of Public Health | September 2018)
http://www.searo.who.int/publications/journals/seajph/en/https://www.who.int/medicines/http://www.searo.who.int/entity/medicines/en/http://www.searo.who.int/entity/medicines/regulation/about/en/https://sustainabledevelopment.un.org/sdg3https://sustainabledevelopment.un.org/
South-East Asia (SEARO)
Accelerating Progress on HIV, Tuberculosis, Malaria, Hepatitis and Neglected Tropical Diseases. A New Agenda for 2016 - 2030
UN Millennium Project. 2005. Prescription for Healthy Development: Increasing Access to Medicines. Report of the Task Force on HIV/AIDS, Malaria, TB, and Access to Essential Medicines, Working Group on Access to Essential Medicines.
The World Health Report 2013. Research for Universal Health Coverage
Essential Medicines and Health Products - Biennial Report 2012–2013
Investing to Overcome the Global Impact of Neglected Tropical Diseases: Third WHO Report on Neglected Diseases 2015
Global Tuberculosis Report 2015. (20th edition)
World malaria report 2015. Geneva: World Health Organization; 2015
http://www.who.int/hiv/en/http://www.who.int/neglected_diseases/en/http://www.who.int/malaria/en/http://www.who.int/tb/en/http://www.who.int/hepatitis/en/
Access and Control Newsletter
Laing, Richard; Rockers, Peter C.; Umeh, Chukwuemeka A.; Wirtz, Veronika J
Boston University School of Public Health
Equitable Access to Essential Medicines: A Framework for Collective Action - WHO Policy Perspectives on Medicines, No. 008, March 2004
Delivering Universal Primary Care Services for Non-communicable Diseases: The Need for Stronger Country Health Systems (Commonwealth Health Ministers' Update 2011, Chapter 4: Improving Disease Management, Access)
NCD Alliance Briefing Paper - Access to Essential Medicines and Technologies for NCDs (Fully Referenced Version). (The NCD Alliance - Putting Non-communicable Diseases on the Global Agenda)
From Burden to "Best Buys": Reducing the Economic Impact of Non-communicable Diseases in Low- and Middle-income Countries
The Global Economic Burden of Non-communicable Diseases (September 2011)
Silent Killer, Economic Opportunity: Rethinking Non-Communicable Disease. Chatham House Briefing Paper, January 2012
Improving Access to Medicines for Non-communicable Diseases in the Developing World. RAND Occasional Papers, OP-349
Prevention and Management of Chronic Disease: A Litmus Test for Health-systems Strengthening in Low-income and Middle-income Countries. (Lancet 2010; 376: 1785–97)
Essential Medicines for Non-Communicable Diseases (NCDs). Background Paper
Access to Medicines from a Health System Perspective
Promotion of Access to Essential Medicines for Non-communicable Diseases: Practical Implications of the UN Political Declaration. (The Lancet - Non-communicable Diseases Series 4, February 2013)
Responding to Industry Initiatives to Increase Access to Medicines and Other Health Technologies in Countries. EMP Policy Brief Series No. 2.0
Disparities in Availability of Essential Medicines to Treat Non-communicable Diseases in Uganda: A Poisson Analysis Using the Service Availability and Readiness Assessment
Access Observatory 2019 Report. Establishing the Foundation for Shared Learning
https://www.accessobservatory.org/http://www.who.int/research-observatory/en/http://www.who.int/topics/noncommunicable_diseases/en/http://www.who.int/medicines/access_use/en/
WHO Expert Committee on the Selection and Use of Essential Medicines, 27 to 31 March 2017 - WHO Technical Report Series, No. 1006 (including 20th WHO Model List of Essential Medicines and 6th WHO Model List of Essential Medicines for Children)
PQMD Guidelines for Quality Medical Product Donations. February 2019
https://www.accessobservatory.org/https://www.who.int/research-observatory/en/https://www.who.int/topics/noncommunicable_diseases/en/https://www.who.int/medicines/access_use/en/
Access to and Rational Use of Medicines at the Facility Level
Medicine Programme Coordination > Programme Coordination
Nigeria - Federal Ministry of Health
WHO Country Office in Nigeria
Access to and Rational Use of Medicines at the Household Level
Access to and Use of Medicines by Households In Uganda. Report of a Survey conducted 2008
Uganda - Ministry of Health
Access to Antibiotics in New Delhi, India: Implications for Antibiotic Policy
Holloway, Kathleen; Kotwani, Anita
Step-by-Step Approach for Development and Implementation of Hospital Antibiotic Policy and Standard Treatment Guidelines
http://www.joppp.org/content/6/1/6
Access to Antiretroviral Drugs in Low- and Middle-income Countries: Technical Report, July 2014
Habiyambere, Vincent; Perriëns, Joseph H
Implementation of the WTO General Council Decision on Paragraph 6 of the DOHA Declaration on the Trips Agreement and Public Health - Health Economics and Drugs Series No. 016
Scaling up Antiretroviral Therapy in Resource Limited Settings : Guidelines for a Public Health Approach
Untangling the Web of Antiretroviral Price Reductions. 16th Edition, July 2013
Increasing Access to HIV Treatment in Middle-income Countries: Key Data on Prices, Regulatory Status, Tariffs and the Intellectual Property Situation
Sources, Quality and Prices of Active Pharmaceutical Ingredients of Antiretroviral Drugs. Results of a 2012 WHO Survey
Transaction Prices for Antiretroviral Medicines from 2010 to 2013: WHO AIDS Medicines and Diagnostics Services: Global Price Reporting Mechanism: Summary Report December 2013
Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Second edition, 2016
Guideline on When to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV. September 2015
http://www.who.int/hiv/amds/en/http://www.who.int/phi/en/
Access to ART and other Essential Medicines in Sub-Saharan Africa: Intellectual Property and Relevant Legislations, September 2007
Musungu, Sisule F.
Access to Cancer Treatment: A Study of Medicine Pricing Issues with Recommendations for Improving Access to Cancer Medication
't Hoen, Ellen
Medicine Prices, Availability, Affordability and Price Components. A Synthesis Report of Medicine Price Surveys Undertaken in Selected Countries of the WHO Eastern Mediterranean Region
The World Medicines Situation 2011 - Medicines Prices, Availability and Affordability
Availability, Price and Affordability of Cardiovascular Medicines: A Comparison Across 36 Countries Using WHO / HAI Data
Mapping the Availability, Price, and Affordability of Antiepileptic Drugs in 46 Countries (Epilepsia, **(*):1–8, 2012)
Priority Medicines for Europe and the World 2013 Update. Background Paper 6 - Priority Diseases and Reasons for Inclusion. BP 6.05 - Cancer and Cancer Therapeutics
Access to Opioid Analgesics: Essential for Quality Cancer Care
The Availability, Pricing and Affordability of Three Essential Asthma Medicines in 52 Low- and Middle-Income Countries
Cancer Medicine Prices in Low- and Middle-Income Countries
Estimated generic prices of cancer medicines deemed cost-ineffective in England: a cost estimation analysis
Informal Advisory Group on the Availability and Affordability of Cancer Medicines, Report of the meeting 4 – 6 April 2018. Geneva, Switzerland World Health Organization; 2018
Potential Price Reductions for Cancer Medicines on The WHO Essential Medicines List. (European Cancer Congress, January 2017, Amsterdam; Abstract #1032; Poster #151)
WHO EML Cancer Medicines Working Group (CMWG), Report of the meeting 22 – 23 March 2018. Geneva, Switzerland World Health Organization; 2018
http://policy-practice.oxfam.org.uk/http://www.who.int/medicines/areas/access/en/http://www.haiweb.org/medicineprices/
Access to Care and Medicines, Burden of Health Care Expenditures, and Risk Protection: Results from the World Health Survey
Graves, Amy Johnson; LeCates, Robert; Reiss, Sheila K.; Ross-Degnan, Dennis; Wagner, Anita K; Zhang, Fang
Access to Care for Patients with Insulin-requiring Diabetes in Developing Countries. Case Studies of Mozambique and Zambia
Beran, David; De Courten, Maximilian; Yudkin, J. S.
Africa (AFRO)
Mozambique; Zambia
Access to Controlled Medications Programme - Framework [French]
Access to Drugs for HIV/AIDS and Related Opportunistic Infections in Nigeria. A Status Report on the Sociopolitical, Economic, And Policy Climate on Drug Availability for People Living with HIV/AIDS (PLWHA) and Recommendations for Future Access
Obileye, Olatubosun; Peterson, Kristin
POLICY Project/Nigeria
Access to Drugs for Treatment of Noncommunicable Diseases
Bollyky, Thomas J.
Price, Availability and Affordability - An International Comparison of Chronic Disease Medicines
Differences in the Availability of Medicines for Chronic and Acute Conditions in the Public and Private Sectors of Developing Countries
The Availability and Affordability of Selected Essential Medicines for Chronic Diseases in Six Low- and Middle-income Countries
Access to Essential Medicines and Standard Treatment for Chronic Diseases
Action Plan for Implementation of the European Strategy for the Prevention and Control of Noncommunicable Diseases, 2012−2016
The World Medicines Situation 2011 - Global Health Trends: Global Burden of Disease and Pharmaceutical Needs
Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020
Global Status Report on Noncommunicable Diseases 2014
http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001485http://www.who.int/medicines/areas/policy/access_noncommunicable/en/
Kotwani, Anita
Access to Essential Medicines in Kenya. A Health Facility Survey (December 2009)
Medicine Programme Coordination > Country Pharmaceutical Profiles
Kenya - Ministry for Medical Services
Kenya - Ministry of Public Health and Sanitation
Access to Essential Medicines in Kenya. A Household Survey (December 2009)
Hogerzeil, Hans V; Laing, Richard; Perehudoff, S. Katrina
https://www.hhrjournal.org/http://www.who.int/medicines/areas/human_rights/en/http://apps.who.int/medicinedocs/permalinks/open/periodicals/non-who-publications/all/english/essential-laws-for-medicine-access-elma-country-profileshttp://www.who.int/gender-equity-rights/understanding/human-rights-definition/en/
Access to Essential Medicines in Pakistan: Policy and Health Systems Research Concerns
Aleem, Noureen; Bigdeli, Maryam; Rashidian, Arash; Zaidi, Shehla


text:
Measuring Scholarly Impact: A Guide for Law School Administrators and Legal Scholars
Gary M. Lucas Jr.
Texas A&M, the public university for which I work, assesses its colleges and departments based partly on scholarly impact and using quantitative metrics. As part of my administrative duties, the law school's dean has assigned me the task of identifying scholarly impact metrics for use in assessing the performance of our law faculty collectively and individually. This Essay discusses the major issues that arise in measuring the impact of legal scholarship. It explains important scholarly impact metrics, including the Leiter score and Google Scholar h‐index, and the major sources of information regarding scholarly impact, including Google Scholar, Westlaw, HeinOnline, SSRN, and bepress.
I intend for this Essay to serve as a guide for law deans and legal scholars interested in measuring the impact of legal scholarship. In addition, university administrators should find it helpful for comparing the impact of their own law faculty's scholarship with the scholarship of law faculties at other universities. The primary obstacle to such comparisons is a dearth of publicly available information. To that end, the Essay recommends that each law school create a Google Scholar profile for its faculty and explains the procedure for doing so. By acting on this recommendation, administrators would dramatically improve our ability to assess the impact of legal scholarship. Moreover, a ranking of faculties by Google Scholar citation count would provide a much‐needed supplement to existing rankings schemes, including ranking schools based on U.S. News peer reputation score.
Part I of the Essay discusses citations, Part II discusses downloads, and Part III makes the case for widespread use of Google Scholar profiles.
Professor of Law and Associate Dean for Assessment, Strategic Analysis and Reporting, Texas A&M University School of Law


RealHotAss . JackMillerB. Britany22. YaryneAmazing.
pakakhontesKaraBabeWernerFitHeartForU .KylieSummerNikitaLoverCathySolisHeartForU .NicoleDarkSWEETCANDIxxSELENEPALMERHelenNoir .Banxfire2LatinasHotssCathySolisHeartForU .DaisyLovveAlleAndLyzTest4theworldAmalieLove .angelicious01AdrenOlinaNightueen11DaisyLovve .sintialatinAnnabelleeShineJulyClaytonROCKYTOM .IrisStunningHornyJUicyForUPanaphilaBritaniLove .StrawberryClaireblackpearlMissEmilyyBelantya .RaisaBellaXxxxLilisenokSugarMilfyBritaniLove .HornyJUicyForULoren3blackpearlAresGod .
NikitaLoverspoiledladyElenaWestermanPleasantFelicity .CelestysMissEmilyyTaylorSSugarMilfy .ElenaWestermanOoSexyDavid25MarieLunatherealalexdough .DaisyLovvespoiledladyPleasantFelicitySquirtMilkHot2 .DanielaHillxDeeaRosaAngelaMilf1NikitaLover .Test4theworldAlisiaBurnKaraBabesintialatin .NicoleDarkWernerFitsintialatinDeeaRosa .littleannnSWEETCANDIxxGirl6plusSweet11hot .JulyClaytonYourAsianTrannyHornyJUicyForUBelantya .HeartForUDanielleForUKatrinaHeartmiasweetgirl .YaryneAmazingDanielleForUDaisyLovveYaryneAmazing .


These are a few questions we would need answered before we can start: How many colors does it print? Is that printing on 1 side or 2? What is the flat/open and finished size? What kind of Paper would you like? Is that cover or text weight? Are you looking for any coatings, example: UV or Aqueous. If this project folds can you tell us how? Example: 11x17 flat folded to 3.7x8.5. If this is a booklet, how many pages including the cover are there? What kind of binding are you looking for? Example: saddle stitch, coil bind. And on what side (long or short) does it bind? The more information you can give us the better and faster we can do our part. Thanks so much for your help. Look for your quote to be ready shortly.
Tell us what your looking for right here.


Slicking hair back – the ultimate greasy hair saviour!
This was me in the Times yesterday. I am loving the hair and make-up, mainly because this hair is so ridiculously time friendly yet still looks chic and cool.
It has to be the ultimate style for getting by with very greasy hair! Simply centre part the hair (make sure it's a sharp centre parting to retain the sleekness of the style) and brush the hair back into a low ponytail. A little product is helpful to tame flyaways and any odds and ends that may be sticking out! A small amount of Frizz-ease Secret Agent finishing cream, or other finishing product would work a treat. Secure the low ponytail and twist hair round until it forms a neat bun. Keywords here: sleek and smooth!
This look needs a bit of make-up going on to contrast with the simplicity of the hair.
I'm loving the dark eye here and the very slightly 'eighties' contouring beneath the cheekbone.
Keep lips fairly natural to avoid looking as though you've just auditioned for a Robert Palmer video.


text:
Richard Grellman AM worked with accounting firm KPMG for 32 years.

He has extensive board experience. He is Chairman of Genworth Mortgage Insurance, IPH Limited and AMP Foundation and Director of The National Health and Medical Research Council Institute for Dementia Research.  He has been involved in extensive fundraising for dementia research. He was Executive Chairman of the Association of Surfing Professionals (ASP), now the World Surf League (WSL), for 10 years. Grellman was also a director of AMP for 11 years, and chairman of the NSW Motor Accidents Authority from 1994 to 2009. He was also until recently Chairman of Bible Society Australia.

In 2007, Richard was appointed a member of the Order of Australia for service to the community, particularly through leadership roles with Mission Australia and fundraising with Variety the Children's Charity, and to the finance and insurance sectors.

References

Living people
Australian business executives
Members of the Order of Australia
Year of birth missing (living people)

redpajama_set_name: RedPajamaWikipedia


text:
Au Courant, Branding, SF/F
In Which SciFi Channel Makes a Boneheaded Marketing Move
Today I happened on a news story that the Sci Fi channel is changing its name. To, uh, "SyFy." I am totally not making this up, guys. This would be merely a head-scratcher if it weren't for the appalling statement offered by channel president David Howe:
"What we love about this is we hopefully get the best of both worlds," Mr. Howe said. "We'll get the heritage and the track record of success, and we'll build off of that to build a broader, more open and accessible and relatable and human-friendly brand."
Do you see what I see right there? They're trying to make a more "human-friendly brand." Does this mean existing viewers loyal to the SciFi brand are... aliens? Robots, maybe? Zombies?
It's not just the stupid name or the insulting reasons behind the change that makes this boneheaded; it's the combo of the two. If they'd wanted to defocus their origin, why on earth wouldn't they switch to something like 'SFC' for Sci Fi Channel (or Center, or Source, or Universe)? This is a common branding mistake, I think, when a company decides in order to get bigger and better it needs to shed the existing fans/customers/readers/viewers who made them a success in the first place. But how did Sci Fi.... er, SyFy get there?
Despite the suggestion on Twitter that the change is either an April Fool's joke that got into the wild early or the result of a chinchilla-staffed marketing department, I actually suspect there is a deeper trend at work. Let's go back to that article on TV Week again.
During its fourth-quarter earnings call, parent General Electric said Sci Fi racked up a double-digit increase in operating earnings despite the beginnings of the recession.
It's not a move caused by poor performance. No, I think the key phrase here is "parent General Electric." Basically I think this is GE discomfited because it perceives SF/F as a tiny niche. SciFi is for pimply nerds with poor social skills who live in their parents' basements. These people, they collect comic books, they've never kissed a girl, they have pallid skin and a weight problem (alternating too fat or too thin for the sake of variety). We've all heard the stereotype, and it's why SF/F is considered a literary ghetto.
But evidence just doesn't support this ridiculous supposition, particularly when it comes to filmed entertainment. If you look at IMDB's top-grossing films of all time for the United States, arguably nine of the top 10 are science fiction or fantasy. Of the top 50, I could only find six where I don't think I could make a compelling case for calling them works of either science fiction or fantasy.
So yeah, GE? Do a little research. And Sci Fi? Stick to your guns. You know you've got the good stuff, and it's mainstream good stuff, too. Go ahead and back out of this misguided attempt to fool people into thinking you're something different. Don't worry, we'll probably forgive you.
Newer PostHappy Ada Lovelace Day
Older PostBinary Thinking


Janir da Cruz, Maya Roinishvili, Eka Chkonia, Patrícia Figueiredo, Michael Herzog; Cholinergic dysfunction might affect backward masking performance: evidence from schizophrenia. Journal of Vision 2018;18(10):968. doi: 10.1167/18.10.968.
In visual backward masking, a briefly presented target is followed by a mask, which decreases performance on the target. We hypothesized that recurrent processing amplifies neural response to the briefly presented target if no mask follows and that this recurrent processing is interrupted when the mask is presented. In this case, neuromodulation, for example of the cholinergic system, may enhance the neural responses to the target. Hence, if neuromodulation is dysfunctional, masking should be strongly deteriorated. Here, we tested schizophrenia patients, a population that is known to have deficits in the cholinergic system, in a masking paradigm while recording their EEG. We found evidence for two mechanisms of neuromodulation: reduced N1 amplitudes and increased trial-by-trial N1 variability. First, N1 amplitudes correlated with performance, and the two were strongly reduced in patients compared to healthy controls. Second, we estimated the N1 variability using a two-step graph-based method and found that patients had higher N1 peak latency variability than controls. After correcting for the latency variability, patients still showed smaller N1 amplitudes than controls. Hence, N1 amplitudes are both diminished and highly variable in patients. Our results suggest that cholinergic system deficits might impair backward masking performance, which is reflected in the EEG N1 component.


Maritime New Zealand (MNZ) has entered the design phase of its Qualifications and Operational Limits Review (QOL Review). This design phase extends from now until the end of September 2010, when the proposed new qualifications and operational limits framework will be released for public consultation. Industry has a voice throughout the design process. It directly involves people from different parts of New Zealand's maritime industry to ensure that the new framework is responsive to industry needs and works in practice, while meeting our international maritime obligations and supporting MNZ's objective of maintaining safe, secure and clean seas.
Relevant, clear and logical qualifications and appropriate operational limits that meet the needs of New Zealand's commercial maritime industry now and in the future, while ensuring the safety of vessels, their crew, passengers and cargo and the protection of the marine environment. Accessible qualifications that are current, best practice and enable New Zealand's certificate holders to operate effectively and safely in New Zealand and abroad.
Portability – ability to obtain recognition of certificates internationally.
The design process will build on the comprehensive information gathered during the community engagement programme conducted last year. This involved more than 400 in-depth interviews with commercial operators and other maritime community representatives throughout New Zealand.
A design reference group including design advisors with in-depth working knowledge of a specific industry area or type of business operation has been convened by MNZ. This will provide a pool of expertise MNZ can call on throughout the design process. MNZ has selected the design advisors from people interviewed last year as part of the QOL Review community engagement programme. They include a mix of masters, owners and operators, engineers, examiners and training providers bringing different perspectives to the design process. The design advisors will work with MNZ specialists to have input to, review and test preliminary designs for the new framework in three workshops to be held during April to July. Their role is to provide independent advice to MNZ, drawing on their personal knowledge and experience. They are not participating as official representatives of any industry sector.
MNZ is holding a series of workshops in July attended by nominated representatives of key industry organisations. Acting on behalf of their organisation, these stakeholder representatives will be asked to review and provide feedback on a proposed framework before it is completed and released for wider industry consultation. They will assist MNZ with testing the new model and identifying potential impacts, risks and transition issues it could have for different parts of the industry. Design advisors and MNZ specialists will also attend these workshops to ensure continuity.
The proposed new QOL framework will be presented to the wider industry for feedback through a national roadshow to be held in October this year. This will start a period of formal consultation with New Zealand's maritime community. MNZ will visit all major ports and regions to talk through the proposal face to face. Industry feedback will be used to fine-tune the framework.
This robust design process will seek to identify solutions to the issues identified in the community engagement programme by current commercial operators and will take a wider view to position the framework to function effectively in the future. It is important that any proposed model addresses the issues of every industry sector consistently and balances industry needs with other obligations and constraints. International recognition of New Zealand maritime qualifications is vital to ensure their portability and to enable career progression.
NZFCF Chief Executive Pete Dawson has been appointed to the Design Reference Group.


Hotel Lilia is situated at one of the most beautiful Greek harbours, Pasalimani, just 5 minutes of the Piraeus harbour.
We offer to our visitors a comfortable, peaceful and clean hotel with a friendly atmosphere.
Hotel Lilia comprises 20 rooms with private bathroom or shower, radio, telephone set and central heating.
All our rooms offer a color TV and air conditioning for a more comfortable stay.
Our other facilities include spacious and well air-conditioned waiting lounges with wireless internet, a bar, a sitting room with color TV and a dining room where the breakfasts are served.
We would like to thank you for your interest in Hotel Lilia and hope to welcome you at our hotel soon.
If you are familiar with LILIA HOTEL, please share your opinion of it with other travelers. Write a review!


5/11/2016 – In his first "Agony Column" Jon Speelman briefly remembers the times when Magnus Carlsen was still a kid and then presents two interesting games by Rudy Van Kamenade, who will soon turn 70. Van Kamenade played these games at the European Senior team Championship in Halkidiki 2016 where he played for Wales. Jon Speelman takes a look at the most instructive moments.
When I launched this column a week ago, I had no idea whether the response to my appeal for games would be a trickle or a flood. I was delighted when I received a veritable tsunami of emails and games. Many thanks to readers for all your input and please keep it coming.
With a large and burgeoning database already there is bound to be a backlog. But if you play something amazing which you want considered for the next week then please try to get it to me by Friday. I'll be writing the columns just before or during the weekend and they will appear here on Wednesdays.
One of my most interesting emails was a win against "Magnus Carlsen aged ten." Unfortunately I had completely misunderstood that this was an app that purported to play like the world champion at that age. Having therefore removed it I'll still briefly mention that by the time I played the flesh and blood Magnus at the Politiken Cup in Copenhagen 2003 he was all of 12. I got some advantage but missed a tactic and was glad when we agreed a draw!
34.Qe5? Qc6 35.Qe8+ Kg7 36.Qe5+ f6 37.Qc3 Draw Agreed.
On to business and two games by Rudy Van Kamenade a player who will be 70 in June and is married to Julie the current Welsh Ladies Champion. Fourteen years ago they moved to Wales and these two games are from the European Senior team Championship in Greece a few weeks ago where Wales came close to winning the bronze medal.
9/17/2017 – This week's games are by Andreas Niedersberger, pictured playing chess against his very beautiful cat, which apparently has a predilection for the Rubinstein French. Andreas gave up chess — a childhood hobby — at age fourteen, and only when his own children had grown up a bit did he return to the game. His two games feature a Tarrasch (or Semi-Tarrasch) and an open Sicilian.
A very enjoyable and informative column as one would expect given the author. His endgame books from the early 80's, "Endgame Preparation" and "Analysing the Endgame", were (and still are) amazing resources. To me Alekhine for the opening, Tal for the middle game, and Speelman for the endgame represent some of the very best in chess writing.
Awesome, thanks so much for doing this; great idea and, speaking on behalf of the chess 'little guys', rather a privilege.


Use our payment calculator to get an estimate on how much your wheelchair van loan will cost per month. The payment amount you see will vary as it does not factor tax, license and other fees. Please give us a call for exact funding terms.


text:
News in Brief 10 June 2020
Post author By Daniel Johnson UN News - Geneva
Post categories In audio, news, UN News
Tags News in Brief
World facing food emergency, says UN chief in call for States to protect vulnerable
COVID-19 spotlights need for States to combat unfulfilled rights for all people, says UN-appointed expert
Zimbabwe: rights experts demand end to abductions and torture
Daniel Johnson UN News - Geneva | Radio Free (2022-01-20T22:42:49+00:00) » News in Brief 10 June 2020. Retrieved from https://www.radiofree.org/2020/06/10/news-in-brief-10-june-2020-9/.
" » News in Brief 10 June 2020." Daniel Johnson UN News - Geneva | Radio Free - Wednesday June 10, 2020, https://www.radiofree.org/2020/06/10/news-in-brief-10-june-2020-9/
Daniel Johnson UN News - Geneva | Radio Free Wednesday June 10, 2020 » News in Brief 10 June 2020., viewed 2022-01-20T22:42:49+00:00,<https://www.radiofree.org/2020/06/10/news-in-brief-10-june-2020-9/>
Daniel Johnson UN News - Geneva | Radio Free - » News in Brief 10 June 2020. [Internet]. [Accessed 2022-01-20T22:42:49+00:00]. Available from: https://www.radiofree.org/2020/06/10/news-in-brief-10-june-2020-9/
" » News in Brief 10 June 2020." Daniel Johnson UN News - Geneva | Radio Free - Accessed 2022-01-20T22:42:49+00:00. https://www.radiofree.org/2020/06/10/news-in-brief-10-june-2020-9/
" » News in Brief 10 June 2020." Daniel Johnson UN News - Geneva | Radio Free [Online]. Available: https://www.radiofree.org/2020/06/10/news-in-brief-10-june-2020-9/. [Accessed: 2022-01-20T22:42:49+00:00]
» News in Brief 10 June 2020 | Daniel Johnson UN News - Geneva | Radio Free | https://www.radiofree.org/2020/06/10/news-in-brief-10-june-2020-9/ | 2022-01-20T22:42:49+00:00
← How the Arakan Army Became Myanmar's Deadliest Insurgency → Bill de Blasio Promised to Change the NYPD. His Courage Failed Him, And Us